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This review analyzes the available literature on the impact of intermittent fasting (IF), a
nutritional intervention, on different aspects of metabolism. The epidemic of metabolic
disturbances, such as obesity, metabolic syndrome (MS), and diabetes mellitus type 2 has
led  to an increase in the prevalence of cardiovascular diseases, and affected patients might
signiﬁcantly beneﬁt from modiﬁcations in nutritional habits. Recent experimental stud-
ies  have elucidated some of the metabolic mechanisms involved with IF. Animal models
have shown positive changes in glucose (lower plasma glucose and insulin levels) and in
lipid  metabolism (reduced visceral fat tissue and increased plasma adiponectin level), and
an  increased resistance to stress. Despite the limited number of samples studied, positive
results have been reported on the impact of IF for human health. IF is reported to improve the
lipid  proﬁle; to decrease inﬂammatory responses, reﬂected by changes in serum adipokine
levels; and to change the expression of genes related to inﬂammatory response and other
factors. Studies on obese individuals have shown that patient compliance was greater for
IF  than other traditional nutritional approaches (calorie restriction), and IF was found to be
associated with low oxidative stress. Recent reports suggest that IF exerts a positive impact
on the metabolic derangements commonly associated with cardiovascular diseases, and
that  it may be a viable and accessible intervention for most individuals. Therefore, further
clinical studies are essential to test the effectiveness of IF in preventing and controlling
metabolic and cardiovascular diseases.
© 2013 Elsevier Editora Ltda. 
Efeitos  do  jejum  intermitente  no  metabolismo  humano
alavras-chave:
ejum
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Esta revisão traz uma análise de dados disponíveis na literatura sobre o impacto do
jejum intermitente, uma modalidade de intervenc¸ão nutricional, em diferentes aspectos
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besidade
índrome metabólica
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metabólica e diabetes mellitus tipo 2, tem ocasionado um aumento na prevalência de
doenc¸as  cardiovasculares, condic¸ões em que os indivíduos afetados apresentam impor-
tantes melhorias advindas de modiﬁcac¸ão nos hábitos alimentares. Estudos experimentais
recentes têm elucidado a modulac¸ão do metabolismo por jejum intermitente. Testes com
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animais têm mostrado alterac¸ões positivas no metabolismo glicídico (valores menores de
glicemia e insulinemia) e lipídico (reduc¸ão no volume de gordura visceral e aumento nos
valores de adiponectina plasmática), além de uma maior resistência ao estresse. Apesar dos
estudos disponíveis apresentarem populac¸ões muito reduzidas, observaram-se resultados
positivos com esta intervenc¸ão também na saúde humana. Os resultados indicam mel-
horias no perﬁl lipídico, reduc¸ão de respostas inﬂamatórias, com reduc¸ão na liberac¸ão de
adipocinas inﬂamatórias e alterac¸ões na expressão de genes relacionados com a resposta
inﬂamatória e de outros fatores. Em indivíduos obesos observou-se uma melhor adesão
ao  jejum intermitente em relac¸ão a intervenc¸ões tradicionais (restric¸ão calórica), além
da  reduc¸ão no estresse oxidativo desta populac¸ão. Dessa maneira, por se tratar de uma
intervenc¸ão  viável e acessível para a maioria dos indivíduos, novos estudos clínicos são
necessários para testar a eﬁcácia desta intervenc¸ão na prevenc¸ão e no controle de doenc¸as
metabólicas e cardiovasculares.
13 El© 20
Introduction
The human genotype is believed to have evolved from
600,000 BC to 25,000 BC, when humans were hunter-
gatherers.1 During this period, major energy oscillations
appear to have selected genes that regulate metabolism for
efﬁcient nutrient usage and increased fat storage, which rep-
resents an evolutionary beneﬁt consistent with the thrifty
genotype theory proposed by James V. Neel.2 While the envi-
ronment changed drastically with urbanization and easy
availability of food, the genotype remains largely unaltered.
This imbalance has resulted in an epidemic of conditions
characterized by metabolic disturbances, such as obesity,
metabolic syndrome (MS), and diabetes mellitus type 2
(DM2).1,3,4
While obesity is easily deﬁned by body composition (body
mass index [BMI] > 30 kg/m2), and DM2  by elevated blood
glucose levels, MS  is recognized by a cluster of metabolic
markers whose importance and contribution have greatly
changed over time. Despite this difference, the three condi-
tions have common pathophysiological backgrounds. Firstly,
all these conditions involve insulin resistance, elevated levels
of plasma lipids, and increased levels of chronic inﬂammatory
mediators. Secondly, the consequent metabolic proﬁle consid-
erably increases cardiovascular risk. Finally, individuals with
any of these conditions can beneﬁt from signiﬁcant lifestyle
changes.5–7 Notably, modiﬁcation of nutritional habits is now
considered extremely important for reducing cardiovascular
risk.8,9
Intermittent fasting (IF) is an interventional strategy
wherein individuals are subjected to varying periods of fas-
ting. IF has recently attracted attention because experimental
studies have highlighted its potential for correcting metabolic
abnormalities.10 This regimen has also shown better adher-
ence than other methods.11
This review analyzes existing data on the impact of IF on
different aspects of metabolism.Methodology
Experimental studies and clinical trials on IF available in the
PubMed database at the time of manuscript preparation weresevier Editora Ltda. 
reviewed. Animal and human studies were searched for by
using the key words “intermittent fasting,” “alternate day
fasting,” and “starvation” either alone or combined with “car-
diovascular risk,” “obesity,” and “metabolic syndrome.”
The ﬁrst search retrieved over 22,000 results, mostly by
using the keyword “starvation” alone (21,735). A detailed
search yielded 26 articles on the impact of fasting or IF on
metabolic parameters related to cardiovascular risk.
Pathophysiological  basis  of  obesity  and  MS
Obesity and MS were the main outcomes analyzed in the stud-
ies on IF.
Adipose tissue is now known to function as an endocrine
organ involved in regulating metabolism, rather than a passive
reservoir for energy storage.12 Adipocytes, mesenchymal cells,
and inﬁltrating macrophages together produce cytokines and
adipokines that have important regulatory effects on inﬂam-
mation, insulin sensitivity, coagulation, vascular homeostasis,
appetite, energy expenditure, etc. When this production is
deregulated, e.g., by excessive adipose tissue, the organ-
ism appears to develop low-grade chronic inﬂammation,
leading to insulin resistance and cardiovascular disease.13
Adipocytes produce important proinﬂammatory adipokines,
such as leptin, tumor necrosis factor alpha (TNF-),  resistin,
angiotensinogen, interleukin-6 (IL-6), and plasminogen acti-
vator inhibitor-1 (PAI-1), as well as nonesteriﬁed fatty acids
and C-reactive protein (CRP), which are atherogenic.14,15
Certain adipokines have cardioprotective action, such
as adiponectin, which is abundant in human circulation.
Adiponectin was primarily investigated for its ability to pro-
mote insulin sensitivity by suppressing gluconeogenesis and
increasing fatty acid oxidation, which in turn reduce triglyc-
eride accumulation in the liver.13,16 Moreover, adiponectin
regulates endothelial function by increasing the produc-
tion of endothelial nitric oxide; by inhibiting endothelial
cell activation and endothelium–leukocyte interaction; by
enhancing phagocytosis; and by suppressing macrophage
activation, macrophage-to-foam cell transformation, and
17–19
Este é um artigo Open Access sob a licença de CC BY-NC-NDplatelet aggregation.
Adipokines might represent the evolutionary pathway that
led excessively nourished humans to obesity, insulin resis-
tance, MS, and cardiovascular disease. Indeed, obese patients
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ith excess visceral fat show increased adipokine expression.
owever, weight loss is related to reduced plasma levels of
etabolically active substances.20
ffects  of  intermittent  fasting  on  animal  models
etabolic mechanisms triggered by IF were well elucidated by
ecent experimental studies. Anson et al.10 investigated glu-
ose metabolism and enhanced neuronal resistance to stress
n C57BL/6 mice subjected to ad libitum diet, IF, or limited
aily food intake for 22 weeks. Neuronal stress was induced
t the end of the 22nd week through an injection of kainate,
 seizure- and neuronal damage-inducing exotoxin. The
F group showed signiﬁcantly lesser histopathological brain
hanges, and lower plasma glucose and insulin levels than the
thers. These ﬁndings were reproduced in male Wistar rats.21
Similarly, a study on the lipid metabolism of male C57BL/6J
ice subjected to alternate-day fasting (ADF) or alternate-
ay 50% calorie restriction (ADCR 50%) showed a signiﬁcant
eduction in the size of adipocytes of both visceral and subcu-
aneous fat. The authors also found that IF causes oscillation
f triglyceride metabolism between anabolism (gluconeoge-
esis and de novo lipogenesis) and catabolism (lipolysis).22
he same group later reported that female C57BL/6J mice
ubjected to four-week IF showed signiﬁcantly reduced vis-
eral fat percentage, increased subcutaneous fat percentage,
ncreased plasma adiponectin levels, and unchanged amount
f fat tissue.11
Mager et al. investigated heart-rate variability in 12
prague-Dawley rats during 16 weeks of nutritional inter-
ention by using an implanted telemetric transistor.23 After
6 weeks, rats in the IF group showed reduced sympathetic
ctivity associated with increased vagal tone. This reduc-
ion might have immunomodulatory effects, which would
ttenuate the release of proinﬂammatory substances, such
s TNF-, IL-6, and IL-18.
ncreased  resistance  to  stress  after  intermittent
asting
esistance to stress might be a reasonable basis for increased
esistance to cardiovascular and endocrine diseases.
Wan et al. evaluated the response to cardiovascular stress
n male Wistar rats undergoing IF by using a telemetric transis-
or, and found that the rats showed rapid return to basal values
f blood pressure and heart rate after induced cardiovascular
tress, and presented no alterations in the plasma levels of
tress biomarkers, such as adrenocorticotropic hormone and
orticosterone, during stress.21 Further, analysis of heart-rate
ariability demonstrated a better norepinephrine response to
tress, thereby indicating an improved autonomic response in
he IF group versus the control group.
Wan et al. later reported that a diet supplemented with
-deoxyglucose (2-DG) - a glycolytic inhibitor and metabolic
tressor - on alternate days could mimic  the effects of IF
n Sprague-Dawley rats.24 They observed that both IF and
-DG supplementation were capable of reducing heart rate,
lood pressure, and glucose levels to similar extents. The1 3;5  9(2):167–173 169
authors suggested that the mechanisms underlying the pos-
itive metabolic response to IF may be attributed to the fact
that periodic metabolic stress can induce adaptive changes
in cardiovascular physiology and glucose metabolism that are
associated with a “less atherogenic” proﬁle.
An alternative cardioprotective action of IF was evaluated
by Ahmet et al.; they maintained 30 Sprague-Dawley rats
under IF for three months and a control group with normal
feeding.25 Thereafter, all animals were submitted to coro-
nary artery ligation to induce myocardial infarction (MI) or to
sham surgery. The IF group showed lower left ventricular (LV)
mass, lower LV wall thickness, and signiﬁcantly lesser ven-
tricular remodeling than the control group. Notably, 23 hours
after surgery, a signiﬁcantly reduced degree of apoptosis and
neutrophil inﬁltration was noted in the IF group with MI,  pos-
sibly contributing to a smaller ventricular size. The authors
proposed that IF induces an ischemic preconditioning in the
cardiac muscle that protects myocardial cells from ischemic
damage. Similar results were recently reported by Wan et al. on
male Wistar rats.26 In this study, plasma adiponectin and IL-
6 concentrations were measured, which showed an increase
in the former and a decrease in the latter. The authors sug-
gested that the observed beneﬁts of IF might be attributed to
increased plasma adiponectin levels.
More recently, Katare et al., performed a study on the
impact of IF started after MI induction and maintained for
six weeks.27 The male Wistar rats subjected to IF showed
a decrease in cardiomyocyte hypertrophy and ﬁbrosis area,
reduced oxidative stress, better cardiac performance, and bet-
ter survival rates than the control group. The authors also
noted an increased expression of the BDNF gene, responsible
for the enhanced expression of vascular endothelial growth
factor (VEGF) in the cardiac muscle; this resulted in increased
angiogenesis and decreased apoptosis.
In another experimental study, streptozotocin was used to
induce diabetes mellitus type 1 before diet intervention in
Sprague-Dawley rats.28 After eight weeks of IF, the diabetic
IF group showed blood pressure levels similar to those of the
non-diabetic control group, indicating that glomerular dam-
ages promoted by diabetes were somehow prevented. Other
ﬁndings were normal blood levels of glucose, albumin, HDL-
C, and blood urea nitrogen; increased resistance to oxidative
stress; and reduced incidence and intensity of degenerative
structures in the kidneys. Changes in the expression of some
genes involved with cellular survival (p53, p38, and Sir 2) were
also demonstrated.
Studies evaluating the potential of IF in the recovery
from spinal cord injury have also shown intriguing results.
Plunet et al. assessed the effect of ADF in a group of male
Sprague–Dawley rats after cervical spinal cord injury.29 The
intervention proved to be neuroprotective, with a 50% reduc-
tion in lesion volume and increased sprouting of corticospinal
axons. The intervention also promoted plasticity; improved
behavioral recovery, evident by improved gait-pattern and
forelimb function during ladder-crossing; and enhanced verti-
cal exploration. Jeong et al. investigated the effect of the same
dietetic intervention, started before or after a different spinal
cord lesion (thoracic contusion) in Sprague–Dawley rats.30
Both groups subjected to the intervention (before or after
the lesion), showed positive results, with a better functional
 a s . 2170  r e v a s s o c m e d b r
recovery, along with improvement of several parameters of
their walking pattern. The prophylactic group (IF started
before the lesion) performed slightly better than the thera-
peutic group (IF started after the lesion). The results were also
superior in beneﬁts when compared with a group of rats con-
suming the same amount of calories as the ADF group (25%
calorie restriction) everyday. Davis et al. also found positive
results assessing not only spinal cord lesion but also traumatic
brain lesion (TBL) induced in Sprague–Dawley rats.31 They
found that fasting for 24 hours after moderate TBL confers
neuroprotection, maintains cognitive function, and improves
mitochondrial function. The results conﬁrm the beneﬁcial
role of this kind of calorie restriction in other organisms.
Metabolic  changes  during  fasting  in  humans
Metabolic changes due to fasting in humans were ﬁrst investi-
gated in the beginning of the century for treating obesity and
other conditions, such as seizure disorders.32–34Kerndt et al. investigated the metabolic effects of long-term
fasting in human subjects who underwent a 36-day com-
plete fasting regimen for religious reasons.35 They noted a
signiﬁcant decrease in blood pressure, reaching signiﬁcance
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on the 33rd day, accompanied by negative sodium balance.
Changes in metabolic fuel were observed soon after the fasting
period started. Plasma glucose levels dropped immediately
at the beginning of the studies and remained low through-
out the fasting period. Lipolysis and ketogenesis increased,
gluconeogenesis remained higher than baseline levels, and
glycogenolysis was reduced to undetectable levels.
Carlson et al. subjected healthy human volunteers to
60 hours of fasting and collected blood samples at 12 and
60 hours.36 They observed a decrease in plasma glucose by
30% and in insulin by 50%; a signiﬁcant increase in the extent
of lipolysis and fat oxidation; and moderate increase in the
extent proteolysis and protein oxidation. This increase of
fat oxidation provides the substrate for gluconeogenesis and
compensates for the decline in carbohydrate oxidation and
glycogenolysis, thus conﬁrming a switch of metabolic fuels.
ADF is considered a variation of complete fasting that is easier
to maintain for longer periods and has remarkable metabolic
beneﬁts. Studies on healthy subjects demonstrated a simi-
lar adaptation of energetic substrates. This action was also
conﬁrmed by changes in the muscular expression of genes,
such as GSK-3,  which is responsible for the regulation of
glycogen synthesis pathways, favoring glycogen reposition.37
IF also down-regulates mTOR expression in muscle tissue,
ttent
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nother important gene responsible for the modulation of
utrient signaling, and could reﬂect lesser protein synthesis
nd increased expression of carnitine acyltransferase 1 (CPT-1)
n muscle tissue, as well as an increase in fat oxidation.38,39
Results from these and other studies on similar popu-
ations have shown improvements in the lipid proﬁle, with
igher HDL-cholesterol levels in women and lower triglyceride
evels in men, and increased muscular expression of Sirt 1
40) −a gene involved with the regulation of food intake, fat
etabolism, cell differentiation, apoptosis, and prevention of
ging.35 In these studies, an increase in stress resistance was
emonstrated after three weeks of intervention.40 A summary
f the main ﬁndings is presented in Fig. 1.
linical  implications
he general health beneﬁts involved with intermittent fasting
n humans still have not been fully explored in the litera-
ure. Johnson et al. described this phenomena after studying
he article by Vallejo, published in 1956 in a Spanish scien-
iﬁc magazine. In his study of elderly subjects living in a
ursing home, Vallejo did not change the overall calorie con-
umption, only the pattern of eating.41 The subjects would
lternate between ad libitum diet for one day, followed by a
ery restrictive diet on the next day. The results were quite
nteresting, revealing an important increase in the lifespan,
emonstrated by a shorter number of days spent in the inﬁr-
ary. It is important to emphasize that there was no calorie
estriction involved in this intervention, thus the results were
 consequence of the meal pattern alterations. Johnson con-
luded that this was probably just the tip of the iceberg, and
hat the health improvements derived from IF are probably
een in very different aspects of the organism, as observed in
ther studies exploring different conditions.41
Some latter studies were designed to evaluate the conse-
uences of this intervention in speciﬁc health conditions. One
nteresting model analyzed consisted of individuals following
amadan.
Ramadan is a holy month in the Islamic calendar, in which
uslims must refrain from eating or drinking during daylight
ours, thereby resulting in approximately 12 hours of fasting.
hese features make Ramadan a natural model to study IF
n humans. Aksungar assessed cardiovascular health in Mus-
im individuals during Ramadan, with special emphasis on
oagulation.42 The results showed improvements in the lipid
roﬁle, with increased HDL-cholesterol levels and decreased
alues of HDL risk factor (CT/HDL), during the fast and 20 days
fter it; decreased levels of D-dimmer and reduced homocys-
eine, which translates in an improved coagulation proﬁle,
ere also observed. Three years later, in a similar study design,
he same author measured inﬂammatory markers levels, such
s IL-6 and CRP, during Ramadan. The results demonstrated
 decrease in the inﬂammatory response, since plasma levels
f IL-6 and CRP were consistently reduced by fasting.43
Allard et al. assessed cellular stress in healthy individuals
44ubjected to IF for three weeks. Serum samples obtained
efore and after the intervention were added to cultures of
uman hepatoma cell line (HepG2). The effects on growth,
tress resistance, and gene expression were observed. HepG21 3;5  9(2):167–173 171
cells were then subjected to acute stress by treatment with
freshly prepared hydrogen peroxide. The results demon-
strated cell proliferation and increased stress resistance. This
study also conﬁrmed previous reports of an increased expres-
sion of the Sirt 1 gene after IF. The results obtained showed
that IF had a signiﬁcantly greater cell-protective effect than
calorie restriction.
Another study on healthy subjects appraised changes
in adipokine levels after the energetic oscillations caused
by IF. After two weeks of intervention, subjects showed an
increase in plasma adiponectin levels and increased insulin
sensitivity in muscle and fat tissue, which was conﬁrmed by
increased lipolysis inhibition.3
Finally, Varady et al. presented a revision of the impact of
IF on the prevention of chronic diseases in healthy human
and animal models.45 Although most human results were
found to be inconclusive, they showed a tendency to improve
metabolic conditions (glycemia and blood lipids), which
would probably reﬂect in cardiovascular risk reduction. The
lack of signiﬁcance found in human studies is probably a
consequence of the short length of the interventions and of
the absence of a control group in most studies, reﬂecting the
need for more  studies to precisely determine the impacts of
this intervention in humans.45
Although there are important differences in the strength
of the results found, these ﬁndings in humans reﬂect the
beneﬁts observed in animal models, and also show similar
underlying mechanisms, such as genetic modulation. Indeed,
the described results motivated the investigation of IF and its
possible therapeutic effects in diseased individuals.
Protective  actions  of  intermittent  fasting  in  obese
individuals
IF for a period longer than a few weeks is difﬁcult for most
individuals, since they tend to develop headaches, dizzi-
ness, and irritability.40 Therefore, an alternative approach -
alternate-day calorie restriction (ADCR) - has been developed
to promote patient compliance. In this approach, patients
have ad libitum and very-low-calorie diet on alternate days
(ranging from 25% to 85% restriction). When tested on obese
individuals, this regimen showed higher adherence scores
than others.22
Johnson et al. investigated the therapeutic properties of
ADCR for two months in ten obese individuals with asthma.46
The study revealed that IF affected improvement in the lipid
proﬁle, systemic inﬂammatory status (reduced serum TNF-
levels), and oxidative stress (decreased levels of reactive oxy-
gen species). The authors concluded that ADCR induces mild
stress, thereby causing cells to adapt by activating antioxidant
mechanisms; this would imply that IF may be beneﬁcial in
other disorders involving inﬂammation and oxidative stress,
such as atherosclerotic heart disease.
The cardio-protective action of IF was examined by Varady
et al.11 16 obese individuals underwent eight weeks of ADCR
25%, i.e., they consumed 25% of their baseline energy needs,
and ad libitum food on alternate days. The study results con-
ﬁrmed the signiﬁcant cardio protective action of IF, such as
weight loss; reduction of fat tissue mass, blood pressure, and
heart rate; and improvements in lipid proﬁle, with decrease in
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total cholesterol and LDL-cholesterol levels, and an increase
in HDL-cholesterol levels.
Conclusions
The development of cardiovascular disease, the leading cause
of death worldwide, is directly connected to lifestyle fac-
tors causing metabolic disorders. Traditional approaches to
counter these risk factors have been proven ineffective in most
individuals. However, IF has recently been shown to have a
positive impact on cardiovascular health.
Few studies conducted hitherto have explored the effec-
tiveness of this intervention in metabolism regulation. The
studies discussed in this paper have mostly been conducted
in very small populations, on healthy individuals, and for short
periods, which limits the strength of the results achieved. Fur-
ther investigations are required to determine the frequency
and/or duration of IF required to exert a positive effect on
metabolism and cardiovascular outcomes.
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